Avrio Biopharmaceuticals Appoints Laura Jones, Ph.D., J.D., M.S., M.B.A., as Vice President of Quality and Regulatory Affairs

IRVINE, Calif., June 6, 2012 /CNW/ - Avrio Biopharmaceuticals, LLC, a leading global cGMP contract aseptic manufacturing organization, announced the appointment of Laura Jones, Ph.D., J.D., M.S., M.B.A., as Vice President of Quality and Regulatory Affairs. Dr. Jones will be responsible to lead and oversee Avrio's quality and regulatory compliance systems.

"With over 25 years of experience in the pharmaceutical and biopharmaceutical industries, Laura offers a wealth of knowledge and experience in quality assurance and regulatory affairs," said William Botha, President of Avrio Biopharma. "I am confident knowing that Laura's in-depth expertise will even further enhance Avrio's robust quality systems to continuously improve the quality of service Avrio provides its clients."

Dr. Jones has served quality assurance and regulatory affairs management roles supporting the pharmaceutical, biopharmaceutical, and medical device industries. Dr. Jones comes to Avrio as a leader from Bayer HealthCare, where she was appointed the position of Quality Assurance Director. Prior to Bayer, Laura maintained leadership roles at many highly established organizations including Valeant Pharmaceuticals International, Inc., Medtronic, Inc., Elan Pharmaceuticals, and Amphastar Pharmaceuticals Company where she was instrumental in developing and enhancing quality and regulatory systems.

Dr. Jones holds an impressive collection of degrees from many of the top universities including a Ph.D. in Microbiology from Louisiana State University, a M.S. in Regulatory Affairs and Advanced Regulatory Affairs Certification from San Diego State University, a M.B.A. in Management/Marketing from the University of Wisconsin-Madison, and a J.D. from the American College of Law.

Avrio Biopharmaceuticals, LLC, acquires the most qualified individuals in the pharmaceutical industry to maintain its prestigious reputation for quality, performance, and innovation, and with the addition of Dr. Jones to the team, Avrio will continue to be recognized as such a company.

Visit us at booth 974 at the BIO International Convention, June 18 – 21, 2012.

Visit www.avriobiopharma.com or call: 866-98-AVRIO (866-982-8746).

About Avrio Biopharmaceuticals, LLC

Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Avrio, along with its Irvine affiliate, offers full cGMP product development support, delivering preformulation/formulation, analytical development, process validation, scale-up studies, packaging and labeling, stability storage and complete analytical CMC testing. Visit www.avriobiopharma.com or call 866-98-AVRIO (866-982-8746).

SOURCE Avrio Biopharmaceuticals, LLC

For further information:

Katee Fry, Marketing Manager, Avrio Biopharmaceuticals, LLC, 1-866-98-AVRIO (1-866-982-8746), katee.fry@avriobiopharma.com


Profil de l'entreprise

Avrio Biopharmaceuticals, LLC

Renseignements sur cet organisme


Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .


Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.


Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.